Safety and efficacy outcomes in patients undergoing pulmonary vein isolation with second-generation cryoballoon
EUROPACE, cilt.17, sa.3, ss.379-387, 2015 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 17 Sayı: 3
- Basım Tarihi: 2015
- Doi Numarası: 10.1093/europace/euu273
- Dergi Adı: EUROPACE
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.379-387
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Hacettepe Üniversitesi Adresli: Evet
Özet
Aims The second-generation cryoballoon (Arctic Front Advance (TM)) (Arc-Adv-CB) has a redesigned injection system which distributes the refrigerant homogenously to the frontal balloon surface. The aim of this study was to compare the efficacy and safety of the Arc-Adv-CB and its predecessor (Arctic Front (TM)) (Arc-CB) in patients who underwent pulmonary vein isolation (PVI) for atrial fibrillation (AF).